Observations following discontinuation of long-term denosumab therapy
Author:
Funder
Amgen
Publisher
Springer Science and Business Media LLC
Subject
Endocrinology, Diabetes and Metabolism
Link
http://link.springer.com/content/pdf/10.1007/s00198-017-3919-1.pdf
Reference35 articles.
1. Adler RA, El-Hajj Fuleihan G, Bauer DC, Camacho PM, Clarke BL, Clines GA, Compston JE, Drake MT, Edwards BJ, Favus MJ, Greenspan SL, McKinney RJ, Pignolo RJ, Sellmeyer DE (2016) Managing osteoporosis in patients on long-term bisphosphonate treatment: report of a task force of the American Society for Bone and Mineral Research. J Bone Miner Res 31:16–35
2. Whitaker M, Guo J, Kehoe T, Benson G (2012) Bisphosphonates for osteoporosis—where do we go from here? N Engl J Med 366:2048–2051
3. Diab DL, Watts NB (2014) Use of drug holidays in women taking bisphosphonates. Menopause 21:195–197
4. McClung M, Harris ST, Miller PD, Bauer DC, Davison KS, Dian L, Hanley DA, Kendler DL, Yuen CK, Lewiecki EM (2013) Bisphosphonate therapy for osteoporosis: benefits, risks, and drug holiday. Am J Med 126:13–20
5. Banks E, Beral V, Reeves G, Balkwill A, Barnes I, Million Women Study Collaborators (2004) Fracture incidence in relation to the pattern of use of hormone therapy in postmenopausal women. JAMA 291:2212–2220
Cited by 173 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. The use of denosumab in osteoporosis – an update on efficacy and drug safety;Expert Opinion on Drug Safety;2024-09-11
2. Denosumab and the Rebound Effect: Current Aspects of Osteoporosis Therapy (Review);Safety and Risk of Pharmacotherapy;2024-06-06
3. Three-year effect of bisphosphonates on bone mineral density after denosumab withdrawal: observations from a real-world study;JBMR Plus;2024-04-30
4. Zoledronate After Denosumab Discontinuation: Is Repeated Administrations More Effective Than Single Infusion?;The Journal of Clinical Endocrinology & Metabolism;2024-04-13
5. A pilot study proposing an algorithm for pubertal induction in cerebral palsy;Journal of Pediatric Endocrinology and Metabolism;2024-02-20
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3